New WBRT Technique Reduces Neurocognitive Decline Risk
By MedImaging International staff writers Posted on 08 Nov 2018 |
Adverse cognition effects of whole- brain radiotherapy (WBRT) can be significantly mitigated by using a hippocampal sparing technique and a neuroprotective agent, claims a new study.
Researchers at Northwestern Medicine Cancer Center (Warrenville, IL, USA) conducted a study in 518 adult patients with brain metastases who were stratified by analysis of prognostic factors and by whether or not they had previously undergone radiosurgery or surgical resection. The patients were randomized to a combination of memantine (a low-affinity glutamatergic antagonist) and WBRT at a dose of 30 Gy in 10 fractions, or to memantine plus WBRT and hippocampal avoidance, again at a dose of 30 Gy in 10 fractions.
The results revealed that at six months, cognitive function failure rates were 59.5% in the hippocampal avoidance arm, compared 68.2% in the control arm, a 24% reduction. Cognitive function failure curves began to separate at three months, maintained through the follow-up period. Following adjustment for treatment factors and age, the additional use of hippocampal avoidance techniques led to a 26% relative risk reduction in cognitive failure compared with WBRT plus memantine, in all age groups. The study was presented at the American Society for Radiation Oncology (ASTRO) annual conference, held during October 2018 in San Antonio (TX, USA).
“Quality of life for patients with brain metastases can be largely driven by their cognitive function, and we've come to understand that WBRT can significantly impact that cognitive function outcome as well as the quality of life associated with it,” said lead author Vinai Gondi, MD. “Conformal avoidance of the hippocampal dentate gyrus using during WBRT plus memantine preserves cognitive function in patients with brain metastases with no difference in toxicity, intracranial progression-free survival rates, or overall survival.”
The hippocampus (named after its resemblance to the seahorse) is a major component of the brains of humans and other vertebrates. The hippocampus belongs to the limbic system and plays important roles in the consolidation of information from short-term, long-term, and spatial memory. It is located under the cerebral cortex, and contains two main interlocking parts: the hippocampus proper (also called Ammon's horn) and the dentate gyrus.
Related Links:
Northwestern Medicine Cancer Center
Researchers at Northwestern Medicine Cancer Center (Warrenville, IL, USA) conducted a study in 518 adult patients with brain metastases who were stratified by analysis of prognostic factors and by whether or not they had previously undergone radiosurgery or surgical resection. The patients were randomized to a combination of memantine (a low-affinity glutamatergic antagonist) and WBRT at a dose of 30 Gy in 10 fractions, or to memantine plus WBRT and hippocampal avoidance, again at a dose of 30 Gy in 10 fractions.
The results revealed that at six months, cognitive function failure rates were 59.5% in the hippocampal avoidance arm, compared 68.2% in the control arm, a 24% reduction. Cognitive function failure curves began to separate at three months, maintained through the follow-up period. Following adjustment for treatment factors and age, the additional use of hippocampal avoidance techniques led to a 26% relative risk reduction in cognitive failure compared with WBRT plus memantine, in all age groups. The study was presented at the American Society for Radiation Oncology (ASTRO) annual conference, held during October 2018 in San Antonio (TX, USA).
“Quality of life for patients with brain metastases can be largely driven by their cognitive function, and we've come to understand that WBRT can significantly impact that cognitive function outcome as well as the quality of life associated with it,” said lead author Vinai Gondi, MD. “Conformal avoidance of the hippocampal dentate gyrus using during WBRT plus memantine preserves cognitive function in patients with brain metastases with no difference in toxicity, intracranial progression-free survival rates, or overall survival.”
The hippocampus (named after its resemblance to the seahorse) is a major component of the brains of humans and other vertebrates. The hippocampus belongs to the limbic system and plays important roles in the consolidation of information from short-term, long-term, and spatial memory. It is located under the cerebral cortex, and contains two main interlocking parts: the hippocampus proper (also called Ammon's horn) and the dentate gyrus.
Related Links:
Northwestern Medicine Cancer Center
Latest Nuclear Medicine News
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment
- Low-Dose Radiation Therapy Demonstrates Potential for Treatment of Heart Failure
- New PET Radiotracer Aids Early, Noninvasive Detection of Inflammatory Bowel Disease